Sessions

Accelerating the Digitalisation Revolution in Cell and Gene Therapy Development
Changing the Cell Therapy Landscape with In-Vivo Therapies: Is this a Viable Alternative for Point of Care Therapeutics?
Achieving Best Practice in Quality Control and Assurance
Implementing New and Enabling Technologies into Existing Processes for Improved Commercial Outcomes
Implementing New and Enabling Technologies into Existing Processes for Improved Commercial Outcomes
Analytics, Data and IT Tech Solutions: An Overview of Best Practices and Technology
Delivery Solutions, Improvements and Alternatives for Gene & Cell Therapy
Industry 4.0 Approaches Transforming Cell and Gene Therapy
Viral Vector Development: Safe and Effective Viral Vectors for Therapeutic Success

Accelerating the Digitalisation Revolution in Cell and Gene Therapy Development

26 Jan 2022
15:30
SPONSORED BY
TrakCel
Global OT/IT Quality Services

15:30 Chairperson’s Opening
Fabio Fachin,  Head, Cell Therapy Process Development and Automation & Digital Technologies, Takeda

15:35 Orchestrating Advanced Therapy Value Chains at an Industrial Scale

  • Challenges ahead as the industry grows and matures
  • Key priorities of life sciences organizations- delivering real value through digital initiatives
  • A two pronged approach to digitalization of Advanced Therapy Value Chains

Anirban Ghosh, Director, Supply Chain Business Systems Architect, Genentech

15:50 The Evolving Digitisation of the Supply Chain

  • Fast track routes for therapies highlight the need to prepare for commercialization and globalization early
  • How the needs driving digitization have evolved as the industry has expanded
  • The need for orchestration solutions to serve a diverse therapy profiles

Matthew Lakelin, Vice President, Business Development and Scientific Affairs, TrakCel

16:05 Implementation of a Digital Ecosystem for C&GT Development & Manufacturing: Strategy Considerations and Examples

Fabio Fachin,  Head, Cell Therapy Process Development and Automation & Digital Technologies, Takeda

16:20 Current Trends in Manufacturing Digitalisation

The presentation will provide an assessment of the current trends with manufacturing automation and digital transformation in the cell and gene therapy space along with unique strategies for startups and early clinical organizations to plan an integrated approach to their automation and information technology roadmap. Emphasis will be placed on understanding the importance of data management, investing in digital transformation roadmap and preparing for product  commercialization.

    • Development of enterprise architecture roadmap to deliver value to your business
    • Address the silos in an organization that make data sharing difficult and the need to bring them together.
    • Ensure proper technology and vendor evaluation with best practices of system implementation.

Robert Lechich, Principal Consultant, Global OT IT QS

16:35 Speaker Q&A and Panel Discussion

Joined by:

Jacob Becraft, Chief Executive Officer, Strand Therapeutics

Dragan Djordjevic, Associate Director of DigCMC and Machine Learning, Takeda

Speakers

Fabio Fachin
Head of Cell Therapy Process Development, Automation and Digital Technologies
Takeda
Anirban Ghosh
Director, Supply Chain Business Systems Architect
Genentech
Matthew Lakelin
Vice President, Business Development and Scientific Affairs
TrakCel
Robert Lechich
Principal Consultant
Global OT/IT Quality Services
Jacob Becraft
Chief Executive Officer
Strand Therapeutics
Dragan Djordjevic
Associate Director, Cell Therapy Robotics, Data Automation and Machine Learning
Takeda